Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit to Link Persons Who Inject Drugs to Integrated Care and Prevention for Addiction, HIV, HCV and Primary Care

NCT04804072 is registered in ClinicalTrials.gov with HIV Prevention Trials Network as lead sponsor.

NCT NCT04804072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04804072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit to Link Persons Who Inject Drugs to Integrated Care and Prevention for Addiction, HIV, HCV and Primary Care
Lead sponsor
HIV Prevention Trials Network
Phase
Not applicable
Overall status
Completed
Start date
June 2, 2021
Completion date
December 17, 2024
Enrollment
447 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

drug use, hiv infections, opioid use, opioid-use disorder